Opendata, web and dolomites

H2020 projects about "immunotherapy"

The page lists 154 projects related to the topic "immunotherapy".

# achronym  title  year 
1 APERIM APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy 2015
2 PROCROP Professional cross-priming for ovary and prostate cancer 2015
3 IMMUNOSHAPE Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells 2015
4 TREGeneration Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes 2015
5 AllergyBLOCK Blocking peanut allergy through protective IgG antibodies 2015
6 SO-CMA Improving the safety of oral immunotherapy for cow's milk allergy in children 2016
7 DC cancer Development and immunological control of dendritic cell cancer 2015
8 ImmunoFarm IgA-based oral therapy for protection of piglets against infection with enterotoxigenic E. coli. 2015
9 VIRION Viruses, Immune stimulation and RNA Interference in Oncology Network 2015
10 DermalTherapy Membrane fusion mediated dermal allergy immunotherapy 2015
11 IMMUTRAIN Training Network for the Immunotherapy of Cancer 2015
12 TIPPDECRA Tolerogenic immunotherapy with peptide-pulsed dendritic cells in rheumatoid arthritis 2016
13 LEGO Multimodal glycoconjugates: a molecular Lego approach for antitumoral immunotherapy 2015
14 ISPIC Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome 2016
15 HIV1ABTHERAPY Antibody-Mediated Therapy of HIV-1 Infection 2016
16 H2020MM04 DC-based immunotherapy to treat Malignant Mesothelioma 2016
17 STREAM Strategies towards Excellence in Immuno-Oncology 2016
18 VACTRAIN TWINNING ON DNA-BASED CANCER VACCINES 2016
19 AML-VACCiN Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia 2016
20 PRECIOUS Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy 2016
21 DynOMIS Dynamic Origins of MHC class I Selector function 2016
22 PIM PROTEOMICS Unravelling PIM kinase signal integration in the T cell response 2017
23 DISTRICT DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS 2017
24 AVITAG Alphaviral Immunotherapy against Glioblastoma 2016
25 ADHERE Aptamer nanostructures dual-targeted to the HER receptor family for cancer therapy 2016
26 CHEMCHECK CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy 2016
27 Immune-senescence Dual targeting of senescence and tumor immunity for cancer therapy 2016
28 INTHER Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy 2016
29 Project ACT Automated autologous cell therapy system 2016
30 STRAVIR Role of the stroma-derived ‘alarmin’ IL-33 in anti-viral immunity 2016
31 DeNovoImmunoDesign Computational Design of Novel Functional Proteins for Immunoengineering 2017
32 BITCAT Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy 2017
33 HYPOXIMMUNO Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia 2016
34 SweetAim Selective glycoimmuno-targeting for cancer therapy 2016
35 EURE-CART EURopean Endeavour for Chimeric Antigen Receptor Therapies 2017
36 IMMUNOSABR Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer 2017
37 EVOLVE Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy 2017
38 STIMUNITY Preclinical validation of a novel immunogenic composition to stimulate innate immunity 2017
39 GAIT From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy 2017
40 POLYBOOST POLYBOOST: Renovating the Polyclonal Immunotherapy 2016
41 LentiFactory MAGIC (MAnufacturing of Gene delivery tools for Industrial and Clinical applications) 2017
42 BGCI Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology 2017
43 GD TCR LIGAND Identification of the ligand of a human public anti-HCMV/cancer γδ T cell receptor 2017
44 CMI2T IA Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs 2017
45 SCALTIE Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy 2017
46 DevoSignGammaDelta Tracking γδ T cell development and TCRγδ proximal signalling 2018
47 Immunometabolomics CD8+ T cell metabolism in anti-tumor response 2017
48 CD4CRISPR A quorum sensing mechanism regulating CD4 T cell proliferation 2017
49 CINK Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers 2018
50 PolyVac Polysaccharide-based membrane for sublingual vaccination 2017
51 IC_IL_EC_2017 Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers 2018
52 THAT IS HUNT Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors 2018
53 TANTUMorNEUVACCINE Neutrophil subtypes: distinct cellular targets for therapeutic intervention 2017
54 TIGITtherapy TIGIT therapy for cancer treatment 2017
55 ACTICELL Precision confiner for mechanical cell activation 2017
56 IMMOVA Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease 2017
57 MEDIVAC Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems 2017
58 ImmuneCheckpointsAD Immune checkpoint blockade for fighting Alzheimer’s disease 2017
59 FATE Functional Biology of Hepatic CD8+ T cells 2017
60 Cellphmed Accurate cell signatures for the advancement of personalized medicine 2017
61 ENLIGHTEN INTEGRATION AND PROPAGATION OF IMMUNOLOGICAL SIGNALS DURING CANCER AND INFECTION 2018
62 INTACt ImmuNogenomics TArgeting Cancer 2017
63 STEPUP Synthetic DCs for a T cEll ProdUction Platform 2017
64 BioProbe-PIT Local molecular profiling of tumor tissue sections: towards personalized immunotherapy 2017
65 LUPUSCARE PRECISION CARE IN SYSTEMIC AUTOIMMUNITY: AN INTEGRATED MULTI-TISSUE/LEVEL APPROACH FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) 2017
66 VDJtargeting Engineering T cells and B cells for Immunotherapy using V(D)J recombination 2017
67 IMMUNISA A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer 2017
68 SENSIT Sensitivity of human tumors to T cell attack 2017
69 TRACE Transfer of multivirus-specific T-cells following transplantation 2018
70 CANCER-DC Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression 2018
71 TissueLymphoContexts Tissue-resident Lymphocytes: Development and Function in “real-life” Contexts 2018
72 CANCER Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life 2018
73 OncoSeq OncoSeq: an innovative single-cell system for immunomonitoring 2017
74 ImmunoFit Harnessing tumor metabolism to overcome immunosupression 2018
75 SI Structural and functional characterization of the ICOS/ICOSL immune complex 2018
76 iaFRET An amplified signal imaging software for prognosis of cancer enabling the evaluation of clinicalefficiency of personalised cancer treatments to an unprecedented level. 2018
77 ToCCaTa Tailoring the functional Capacity of Cytotoxic T cells for future Therapies 2018
78 SmallDrugRheuma Discovery of Immune Therapeutic Targets and Immunomodulators for the Development of Novel Therapies in Rheumatoid Arthritis. 2018
79 IMMUNOMARK Omics integration for precision cancer immunotherapy 2018
80 TCELLTIGIT Structural characterization of immune signaling protein TIGIT using x-ray crystallography and cryo-electron microscopy 2019
81 UTILIUM Unraveling The Immune Landscape In Uveal Melanoma 2018
82 SPeNTa-Brain Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours 2019
83 ONCOTHERANOSTICS Advanced Theranostic Nanomedicines for Oncology. Development of new combinatorial therapies for primary and metastatic Breast Cancer. 2019
84 Gal3-BrainMets A novel immunotherapy against brain metastasis: Anti-Galectin-3 2019
85 InTheMLLrBALL Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia 2018
86 IMM-GNRs Human IMMune profiling of Graphene NanoRibbons 2018
87 RE-IMMUNE Intelligent Nano-encapsuled siRNA for Restoring Immune Cell Response to Cancer 2019
88 IN-3D-CAN Instrumented 3D-Printed Miniature Muscles for Cardiotoxicity Screens of Cancer Therapies 2018
89 GDCOLCA Understanding gamma delta T cells in colon cancer metastasis 2018
90 QuanTII Quantitative T cell Immunology and Immunotherapy 2018
91 SUMMIT Stepping Up mRNA Mutanome Immunotherapy 2018
92 CARAMBA SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease 2018
93 SOLUPORE Solupore® - Enabling the Manufacture of Affordable New Treatments to Cure Cancer 2018
94 AllergyExplorer Automation of novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results 2018
95 Oncarin A scientifically proven Microbiome immunotherapy for the treatment of colorectal cancer 2018
96 UNLEASHAD Unleashing the curative potential of cancer immunotherapy 2018
97 SOMIT Leveraging a novel platform technology to develop a first-in-class immunotherapy for Celiac Disease 2018
98 CL-IO Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis 2018
99 EPIC Enabling Precision Immuno-oncology in Colorectal cancer 2018
100 I-DireCT Immune DIREcted and Cancer-selective immunoTherapy 2019
101 STIMUNO Searching for novel strategies improving cancer immunotherapy 2019
102 COR1-TCELL Analysis of the role for coronin 1-dependent cell density signalling in T-cell homeostasis 2019
103 MechanoIMM Mechanical Immunoengineering for Enhanced T-cell Immunotherapy 2018
104 ImmunoCode Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy 2018
105 NextGen IO Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology 2019
106 POLYMMUNE Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment 2019
107 TCRabX Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors 2019
108 CANCEREVO Deciphering and predicting the evolution of cancer cell populations 2019
109 ImmunoBioSynth Synergistic engineering of anti-tumor immunity by synthetic biomaterials 2019
110 AllergyVAX Next generation allergen immunotherapy based on specifically modified recombinant hypoallergens 2018
111 iReceptor Plus ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY 2019
112 SYNKIT Synthetic Natural Killer Cells for Immunotherapy 2020
113 GlyCANswer Decoding the Cancer Glycoproteome Driven Immune Response 2019
114 MHT-ImmunoEnhancer Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment 2019
115 ImmunoMECH High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment 2019
116 Need2immune Personalized liposomal cancer vaccines within days by rapid formulation screening 2019
117 MGLycan Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer 2019
118 ARGONAUT ARGONAUT: from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy 2019
119 IMMUcan Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts 2019
120 CAN-IT-BARRIERS Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors 2020
121 PROTEUS Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection 2019
122 ONCO-BOOST Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies 2019
123 SPLITVAC Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines 2019
124 MEDIVAC Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems 2019
125 VACCIBIOME Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy 2019
126 ARTimmune Programmable ARTificial immune systems to fight cancer 2019
127 Anti-L1CAM Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients 2019
128 PAVE A nanovaccine Approach for the treatment of Pancreatic Cancer 2019
129 HIL PT System A revolutionary, cost effective, ultra-compact proton therapy system for cancer treatment 2019
130 ADAMtx ADAMtx: Development of Alzheimer’s immunotherapy by harnessing the natural reparative properties of microglia 2019
131 Immune-Image Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies 2019
132 QUALITOP Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management 2020
133 MaxONCO A cancer vaccine to boost body’s natural defences to fight chordoma and head and neck cancer 2020
134 ONCORELIEF A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment. 2020
135 TrojanDC TrojanDC 2019
136 Synthetic T-rEX A synthetic biology approach for T cell exhaustion 2020
137 RARITY RAtional design of canceR ImmunoTherapY: one size does not fit all 2019
138 InterTAU Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs 2020
139 STI-001 Turn Cancer Immunotherapy Effective in Most Patients 2019
140 HDM-FUN Host directed medicine in invasive fungal infection 2020
141 MISTRAL Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination 2020
142 ImmunoSep Personalized immunotherapy in sepsis: a precision medicine based approach 2020
143 MATCH Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research 2020
144 Meta-Targeting Macro-Nanomedicine to Treat Metastatic Cancer 2020
145 TrojanDC Harnessing dendritic cell reprogramming for cancer immunotherapy 2020
146 NATURE-ETN Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification 2020
147 MelImmuneOrg Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy 2020
148 TESTIMONY Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity 2020
149 Hemstem Targeting leukaemia by modulating hematopoietic stem cell competitiveness 2020
150 BraINstorm Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment 2020
151 MITafterVIT Unravelling maintenance mechanisms of immune tolerance after termination of venom immunotherapy by means of clonal mast cell diseases 2020
152 ONCO-VAX A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine 2020
153 Immuno-Predictor Mechanical Biomarkers for Prediction of Cancer Immunotherapy 2020
154 PRECISMEDLYM Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine. 2020